Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nägga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K.

Clin Chem. 2001 Oct;47(10):1776-81.

PMID:
11568086
[PubMed - indexed for MEDLINE]
Free Article
2.

Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitations.

Burkhard PR, Fournier R, Mermillod B, Krause KH, Bouras C, Irminger I.

Clin Chem Lab Med. 2004 Apr;42(4):396-407.

PMID:
15147150
[PubMed - indexed for MEDLINE]
3.

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA.

Clin Chem. 2010 Feb;56(2):248-53. doi: 10.1373/clinchem.2009.130518. Epub 2009 Oct 15.

PMID:
19833838
[PubMed - indexed for MEDLINE]
Free Article
4.

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K.

JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064.

PMID:
19622817
[PubMed - indexed for MEDLINE]
5.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
[PubMed - indexed for MEDLINE]
6.

Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.

Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A, Kluenemann H, Wieland W, Hajak G.

Neurobiol Aging. 2006 Sep;27(9):1202-11. Epub 2005 Aug 8.

PMID:
16085339
[PubMed - indexed for MEDLINE]
7.

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

Maddalena A, Papassotiropoulos A, Müller-Tillmanns B, Jung HH, Hegi T, Nitsch RM, Hock C.

Arch Neurol. 2003 Sep;60(9):1202-6.

PMID:
12975284
[PubMed - indexed for MEDLINE]
8.

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N.

Neurosci Lett. 2007 May 23;419(1):18-22. Epub 2007 Apr 6.

PMID:
17482358
[PubMed - indexed for MEDLINE]
9.

CSF levels of beta-amyloid 1-42, tau and phosphorylated tau protein in CADASIL.

Formichi P, Parnetti L, Radi E, Cevenini G, Dotti MT, Federico A.

Eur J Neurol. 2008 Nov;15(11):1252-5. doi: 10.1111/j.1468-1331.2008.02277.x. Epub 2008 Sep 18.

PMID:
18803653
[PubMed - indexed for MEDLINE]
10.

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P.

Neurology. 2004 May 11;62(9):1580-4.

PMID:
15136685
[PubMed - indexed for MEDLINE]
11.

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.

Stomrud E, Hansson O, Minthon L, Blennow K, Rosén I, Londos E.

Neurobiol Aging. 2010 Feb;31(2):215-23. doi: 10.1016/j.neurobiolaging.2008.03.025. Epub .

PMID:
18462837
[PubMed - indexed for MEDLINE]
12.

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM.

JAMA. 2003 Apr 23-30;289(16):2094-103. Erratum in: JAMA. 2007 Oct 3;298(13):1516.

PMID:
12709467
[PubMed - indexed for MEDLINE]
13.

Neuropsychological and behavioural correlates of CSF biomarkers in dementia.

Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Mariën P, De Deyn PP.

Neurochem Int. 2006 Mar;48(4):286-95. Epub 2006 Jan 24.

PMID:
16434124
[PubMed - indexed for MEDLINE]
14.

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.

Biol Psychiatry. 2008 Nov 15;64(10):850-5. doi: 10.1016/j.biopsych.2008.02.016. Epub 2008 Apr 8.

PMID:
18395699
[PubMed - indexed for MEDLINE]
15.

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, Förstl H, Kurz A.

Neurology. 2002 Jun 11;58(11):1622-8.

PMID:
12058089
[PubMed - indexed for MEDLINE]
16.

CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.

Agren-Wilsson A, Lekman A, Sjöberg W, Rosengren L, Blennow K, Bergenheim AT, Malm J.

Acta Neurol Scand. 2007 Nov;116(5):333-9.

PMID:
17922727
[PubMed - indexed for MEDLINE]
17.

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L.

Lancet Neurol. 2006 Mar;5(3):228-34. Erratum in: Lancet Neurol. 2006 Apr;5(4):293.

PMID:
16488378
[PubMed - indexed for MEDLINE]
18.

Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid.

Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W.

Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23.

PMID:
17384003
[PubMed - indexed for MEDLINE]
Free Article
19.

Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR.

J Neurol. 2009 Sep;256(9):1540-50. doi: 10.1007/s00415-009-5160-0. Epub 2009 May 6.

PMID:
19418113
[PubMed - indexed for MEDLINE]
20.

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A.

Arch Neurol. 2002 Nov;59(11):1729-34.

PMID:
12433260
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk